Jump to content
Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes / VI. Conclusion
Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes / VI. Conclusion
Contents
Chapter
Expand
|
Collapse
Page
1–12
Titelei/Inhaltsverzeichnis
1–12
Details
13–15
I. Introduction
13–15
Details
16–30
II. Novozymes – a Long and Hard Journey to Patent Validity
16–30
Details
A. The Glucoamylase
Details
B. The Patent
Details
C. The Proceedings on Patent Infringement
Details
D. The Proceedings on Patent Validity
Details
1. The Patent Reexamination Board
Details
2. The Courts of First Instance and Second Instance
Details
3. The Supreme Court
Details
E. Comments – a Good Will, but also a “Chicken Rib”
Details
31–43
III. Homology as an Indication of Confidence
31–43
Details
A. Supporting Data for Homology Claims is Not Necessary for the Patent Law
Details
B. Supporting Data for Homology Claims is an Overwhelming Burden
Details
C. Rethinking the Role of Homology Language
Details
1. The Homology Language
Details
2. The Technical Meaning of Homology
Details
D. Species of Origin is Not an Effective Limitation
Details
E. Concluding Remarks
Details
44–55
IV. Novozymes may Create an Unclaimable Gap
44–55
Details
A. Inventive Step and Support are One-Dimensionally Aligned by Homology
Details
B. Disparity in Views on Homology Creates an Unclaimable Gap
Details
C. The Unclaimable Gap May Constitute a Discrimination
Details
D. Downregulating Inventive Step is Not a Feasible Option
Details
56–63
V. Novozymes Mingles Sufficient Disclosure and Support
56–63
Details
A. Sufficient Disclosure and Support Have Different “Prior Art”
Details
B. Novozymes Tests Support Using the Standard of Sufficient Disclosure
Details
C. An Example Test Given by the EWHC
Details
D. On Non-Working Variants – How to Avoid a “Negative Gap”?
Details
64–66
VI. Conclusion
64–66
Details
67–68
Annex I: Sequences of Cytochrome c from 17 Different Species
67–68
Details
69–72
List of Works Cited
69–72
Details
Durchsuchen Sie das Werk
Geben Sie ein Keyword in die Suchleiste ein
CC-BY
Access
Aegis or Achilles Heel: The Dilemma of Homology in Biopatents in the Wake of Novozymes , page 64 - 66
VI. Conclusion
Autoren
Qinghua Yang
DOI
doi.org/10.5771/9783845292717-64
ISBN print: 978-3-8487-5021-4
ISBN online: 978-3-8452-9271-7
Chapter Preview
Chapter Preview
Share
Download PDF
Download citation
RIS
BibTeX
Copy DOI link
doi.org/10.5771/9783845292717-64
Share by email
Video schließen
Share by email Nomos eLibrary
Recipient*
Sender*
Message*
Your name
Send message
This site is protected by reCAPTCHA and the Google
Privacy Policy
and
Terms of Service
apply.
